These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 9551238

  • 1. In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections.
    Gimeno C, Borja J, Navarro D, Valdés L, García-Barbal J, García-de-Lomas J.
    Chemotherapy; 1998; 44(2):94-8. PubMed ID: 9551238
    [Abstract] [Full Text] [Related]

  • 2. Synergistic interaction between ofloxacin and cefotaxime against common clinical pathogens.
    Jenkins SG, Lewis JW.
    Infection; 1995; 23(3):154-61. PubMed ID: 7499004
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial interactions (synergy) of teicoplanin with two broad-spectrum drugs (cefotaxime, ofloxacin) tested against gram-positive isolates from Germany and the United States.
    Jones RN, Marshall SA, Grimm H.
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):87-94. PubMed ID: 9368084
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interaction of clindamycin and cefpimizole (U63196E) in vitro against aerobic gram-negative rods and aerobic gram-positive cocci.
    Welch WD, Bawdon RE, Luttrell B, Goodson S.
    J Antimicrob Chemother; 1984 Nov; 14(5):553-6. PubMed ID: 6511709
    [Abstract] [Full Text] [Related]

  • 13. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M, Ramakrishnan R, Ramesh S, Murugan N.
    Ophthalmic Res; 2012 Nov; 47(1):52-6. PubMed ID: 21720185
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics.
    Nix DE, Schentag JJ.
    Diagn Microbiol Infect Dis; 1995 Nov; 22(1-2):71-6. PubMed ID: 7587053
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Susceptibility of clinical isolates to cephalexin, cefazolin and cefotaxime.
    Gupta BL, Tahlan A, Dogra V, Rattan A, Bhujwala RA, Shriniwas.
    Indian Pediatr; 1989 May; 26(5):466-71. PubMed ID: 2599615
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. International Study Group.
    Verbist L.
    Scand J Infect Dis Suppl; 1993 May; 91():14-24. PubMed ID: 8290899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.